SCHEMBL8207384

SCHEMBL8207384

O=[N+]([O-])c1cccc2c1Oc1ccccc1N=C2N1CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.57
LMNA P02545 1/20 0.54
HTT P42858 1/20 0.54
ALDH1A1 P00352 5/20 0.53
PKM P14618 1/20 0.53
KDM4E B2RXH2 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
ALDH3A1 P30838 1/20 0.48
DRD2 P14416 2/20 0.47
DRD1 P21728 1/20 0.47
MAPK1 P28482 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2D6 P10635 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204367 0.85 DRD1 (0.55) LMNAALDH1A1KDM4EALDH3A1DRD2
SCHEMBL8204046 0.82 ALDH1A1 (0.52) L3MBTL1LMNAALDH1A1KDM4EALDH3A1
SCHEMBL8506985 0.78 HRH4 (0.62) LMNASMN1; SMN2DRD2DRD1MEN1
SCHEMBL8994839 0.75 DRD2 (0.67) HTTALDH1A1KDM4EALDH3A1DRD2
SCHEMBL8203911 0.75 DRD2 (0.75) LMNAALDH1A1KDM4EALDH3A1DRD2
SCHEMBL9050765 0.75 ALDH1A1 (0.57) ALDH1A1KDM4EALDH3A1DRD2DRD1
SCHEMBL8202569 0.72 DRD1 (0.64) LMNAALDH1A1KDM4EALDH3A1DRD2
SCHEMBL8203933 0.71 DRD2 (0.74) LMNAALDH1A1KDM4ESMN1; SMN2ALDH3A1
SCHEMBL8204038 0.71 DRD2 (0.69) LMNAALDH1A1KDM4ESMN1; SMN2ALDH3A1
SCHEMBL8204496 0.70 DRD2 (0.77) LMNAHTTALDH1A1SMN1; SMN2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103715-A COMPOUNDS THAT BIND TO THE DOPAMINE D4 RECEPTOR AND THEIR USE AS ANXIOLYTIC AGENTS, TREATMENT FOR SCHIZOPHRENIA, AND DRUG SCREENING; SIDE EFFECT REDUCTIOON ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-15 US disclosed
US-5538965-A TREATMENT OF PSYCHOLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA AND ANXIETY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1996-07-23 US disclosed